The Trump administration is seeking industry input as it pushes to increase domestic production of critical generic drugs.
Doctors say the growing popularity of supplement stacking has exposed more Americans to botanicals like ashwagandha that can ...
Chlorthalidone has been recalled for the second time in three months, while some exenatide GLP-1 pens may contain no ...
Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns affecting your ...
Learn when a drug holiday may be safe for ADHD medications, GLP-1s and osteoporosis drugs—and when stopping medication can be ...
More older adults are taking five or more medications, but potentially dangerous drug combinations appear to be declining ...
I went to D.C. to push for greater accountability and stronger safety protections for patients who rely on brand-name and ...
In December 2024, Marjorie Tingley’s adult sons received an urgent email from the dementia care unit at Vista Grande Villa, a Michigan senior living community. They were told that their 85-year-old ...
New FDA-approved Alzheimer's drugs — Aduhelm, Leqembi, and Kisunla — have shown side effects, including brain bleeds and swelling. Are they worth the risk?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results